NO20073395L - Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer - Google Patents

Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Info

Publication number
NO20073395L
NO20073395L NO20073395A NO20073395A NO20073395L NO 20073395 L NO20073395 L NO 20073395L NO 20073395 A NO20073395 A NO 20073395A NO 20073395 A NO20073395 A NO 20073395A NO 20073395 L NO20073395 L NO 20073395L
Authority
NO
Norway
Prior art keywords
gastric
coating composition
composition containing
resistant
sticking agent
Prior art date
Application number
NO20073395A
Other languages
English (en)
Norwegian (no)
Inventor
George Reyes
Thomas Farrell
Kurt Fegely
Ali Rajabi-Siahboomi
Budhi Simon
Cara Young
Original Assignee
Bpsi Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36588225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073395(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bpsi Holdings Inc filed Critical Bpsi Holdings Inc
Publication of NO20073395L publication Critical patent/NO20073395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NO20073395A 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer NO20073395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63708304P 2004-12-17 2004-12-17
PCT/US2005/046326 WO2006066264A1 (en) 2004-12-17 2005-12-16 Enteric film coating composition containing enteric polymer micronized with detackifier

Publications (1)

Publication Number Publication Date
NO20073395L true NO20073395L (no) 2007-09-07

Family

ID=36588225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073395A NO20073395L (no) 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Country Status (15)

Country Link
US (1) US20060134216A1 (pt)
EP (1) EP1827390A1 (pt)
JP (1) JP2008524257A (pt)
KR (1) KR20070094627A (pt)
CN (1) CN101080217B (pt)
AR (1) AR051722A1 (pt)
AU (1) AU2005316235A1 (pt)
BR (1) BRPI0518575A2 (pt)
CA (1) CA2586425A1 (pt)
IL (1) IL183579A0 (pt)
MX (1) MX2007007221A (pt)
NO (1) NO20073395L (pt)
TW (1) TW200626185A (pt)
WO (1) WO2006066264A1 (pt)
ZA (1) ZA200704311B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2051704B1 (de) * 2006-08-18 2012-04-18 Evonik Röhm GmbH Pharmazeutische Zusammensetzung mit kontrollierter Wirkstoffabgabe für Wirkstoffe mit guter Löslichkeit in Wasser
EP2429504A4 (en) * 2009-05-12 2013-05-01 Bpsi Holdings Llc FILM COATINGS WITH DECEPTORS IN FINE PARTICLE SIZES AND SUBSTRATES COATED THEREFOR
BRPI1007725A2 (pt) 2009-05-12 2016-02-16 Bpsi Holdings Llc composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma
WO2011136376A1 (ja) * 2010-04-30 2011-11-03 武田薬品工業株式会社 腸溶性錠剤
US8920840B2 (en) * 2010-04-30 2014-12-30 Takeda Pharmaceutical Company Limited Enteric tablet
WO2014159814A1 (en) * 2013-03-13 2014-10-02 Patricia Oliver Formulations and tablets for treatment or prevention of neurological disorders
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
CN111954521B (zh) * 2018-04-12 2023-02-17 Bpsi控股有限责任公司 酸化包衣和由其包衣的抗崩解基质
US11458104B1 (en) 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN116617174B (zh) * 2023-05-12 2024-03-08 石家庄四药有限公司 一种含硫酸氢氯吡格雷和阿司匹林的片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656457A (en) * 1900-05-11 1900-08-21 Isaac Hirsch Knife.
US2595076A (en) * 1949-09-19 1952-04-29 Hudson Bay Mining & Smelting Selective flotation of zinc
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
CN1162917A (zh) * 1994-10-07 1997-10-22 伯温德药品服务公司 肠内涂层组合物，用其涂覆的方法和涂覆制品
CN1093855C (zh) * 1995-09-21 2002-11-06 帕斯医药股份有限公司 新的含有对酸不稳定的奥美拉唑的组合物及其制备方法
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
EP1272165B1 (en) * 2000-02-10 2010-12-01 BPSI Holdings, Inc. Acrylic enteric coating compositions
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US6703004B2 (en) * 2002-04-03 2004-03-09 Revlon Consumer Products Corporation Method and compositions for bleaching hair
US20040255399A1 (en) * 2003-06-23 2004-12-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method and compositions for coloring hair with taurate copolymers

Also Published As

Publication number Publication date
US20060134216A1 (en) 2006-06-22
KR20070094627A (ko) 2007-09-20
CN101080217B (zh) 2012-07-18
CA2586425A1 (en) 2006-06-22
AU2005316235A1 (en) 2006-06-22
WO2006066264A1 (en) 2006-06-22
ZA200704311B (en) 2008-06-25
CN101080217A (zh) 2007-11-28
BRPI0518575A2 (pt) 2009-04-28
TW200626185A (en) 2006-08-01
JP2008524257A (ja) 2008-07-10
EP1827390A1 (en) 2007-09-05
MX2007007221A (es) 2007-08-14
AR051722A1 (es) 2007-01-31
IL183579A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
MXPA05008491A (es) Sistemas de recubrimiento de pelicula nacarada y substratos recubiertos con la misma.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2008002573A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
EP2586778A3 (en) Pyridazinone derivatives useful as glucan synthase inhibitors
GEP20156348B (en) Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
MA34104B1 (fr) Revêtements améliorés à faible teneur en dioxyde de titane
EP2261236A3 (en) Composition for proteasome inhibition
MX2008013040A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1.
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
NO20083309L (no) Dynamiske terskler for betingede formater
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0309142C1 (pt) suspensão de microcápsulas em uma fase líquida aquosa, que permite a liberação modificada de pelo menos um princípio ativo com exclusão da amoxicilina e que é destinada a ser administrada por via oral
BRPI0714417B8 (pt) método para fabricar uma composição de cuidado oral, de cuidado pessoal, limpadora e/ou de cuidado doméstico
NO20080002L (no) Formuleringer av konjugerte ostrogener og bazedoxifen
NO20076515L (no) Hydantoinforbindelser
MA31151B1 (fr) Inhibiteurs de mapk/erk kinase
MX2008016426A (es) Derivados de alquilpiridazina como inhibidores de 11 beta hidroxiesteroide deshidrogenasa tipo 1(11b-hsd 1).
MX2010004501A (es) Inhibidor de la proteina de activacion de 5-lipoxigenasa (plap).
RU2014122994A (ru) Пленкообразующие композиции для зубов
MA29775B1 (fr) Derives de pyrazolone
BRPI0408240A (pt) composto, utilização de um composto e composição farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application